Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F3PCZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,072
Award facts
- Contract value 100% obligated
- $35,072.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a firm fixed price ceiling value of $35,072.28 and ultimate completion date of November 17, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. Dupixent is a prescription biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, and this delivery order reflects AmerisourceBergen's extensive portfolio of specialty pharmaceutical products. The company's DLA prime vendor contract enables it to supply a comprehensive range of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F3PCZ?
SPE2DR26F3PCZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F3PCZ worth?
The government has obligated $35,072 on SPE2DR26F3PCZ.
Is contract SPE2DR26F3PCZ an order under another contract?
Yes. SPE2DR26F3PCZ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PCZ competed?
The extent of competition for SPE2DR26F3PCZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award